The largest database of trusted experimental protocols

5 protocols using hrp labeled anti mouse igg

1

Quantifying PD-L1 Expression in Cancer Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Amounts of PD-L1 mini-body in media of cancer cells infected with 10 vp/cell of HDPD-L1 alone, Onc.Ad alone or with CAd-VECPD-L1 (Onc.Ad:HDAd=1:10) were quantified with ELISA based assay. Media of cancer cells infected with Ads were added to Immulon 2 96-well plate (VWR). Recombinant HA-tag fusion protein (Alpha Diagnostic Intl Inc.) was used as a standard. After blocking with PBS-T containing 3% BSA, anti-HA monoclonal antibody (Clone 5B1D10; Thermo Fisher Scientific) was added to the plate and incubated at 4°C for 24 hours. After washing, HRP labeled anti-mouse IgG (BioRad) was added and incubated at room temperature for 1 hour and then we developed the washed plate.
+ Open protocol
+ Expand
2

PD-L1 Binding Assay Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Immulon 2 high binding 96-well plate (VWR) was coated with 500 ng/well of recombinant human PD-L1 (BioVision). After blocking plate with PBS-T containing 3% BSA, serially diluted media of A549-infected with 1,000 vp/cell of HDegfp or HDPD-L1 mini were added and incubated at 4°C for 24 hours. Serially diluted anti-human PD-L1 antibody starting from 10 μg/well (BioLegend) was used as a positive control. After washing plate with PBS-T, HRP-labeled anti-human IgG for PD-L1 mini-body detection or HRP labeled anti-mouse IgG (BioRad) for anti-human PD-L1 and isotype antibody detection were added and incubated at room temperature for 1 hour and then we developed the washed plate. Absorbance was measured using Tecan reader (TECAN).
+ Open protocol
+ Expand
3

Minibody Binding ELISA for PD-L1, PD-1, and CTLA-4

Check if the same lab product or an alternative is used in the 5 most similar protocols
The minibody binding ELISA assay has been described previously [10 (link)]. Briefly, Immulon 2 high binding 96-well plate (VWR, Radnor, PA) was coated with 500 ng/well of recombinant human PD-L1, PD-1, or CTLA-4 (BioVision, Milpilas, CA, USA). After blocking plate with PBS-T containing 3% BSA, serially diluted media containing minibody or media from GFP-transfected cells were added and incubated at 4 °C for 24 h. Serially diluted IgGs (Biolegend, San Diego, CA, USA) were used as positive controls with isotype IgGs serving as negative controls. HRP-labeled anti-human IgG for minibody detection or HRP-labeled anti-mouse IgG (BioRad, Hercules, CA, USA) for anti-human antibody detection were added and incubated at room temperature for 1hr and then developed. Absorbance was measured using Tecan plate reader (TECAN, Männedorf, Switzerland).
+ Open protocol
+ Expand
4

SDS-PAGE and Western Blot Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Recombinant proteins were fractionated by SDS-PAGE in 12% mini-gels and transferred to polyvinyldifluoride (PVDF) membranes (Merck-Millipore) under semidry conditions. Membranes were blocked with 1% gelatine in PBS for 1 h at RT, rinsed with PBST and incubated either with monoclonal antibody 3D10 [14 (link)] for detection of HaPyV VP1-derived chimeric proteins, or in-house developed monoclonal antibody against TSPyV VP1 protein (clone 17A5) for detection of TSPyV VP1-derived chimeric proteins for 1 h at RT. After rinsing in PBST, the membranes were incubated with HRP-labeled anti-mouse IgG (Bio-Rad Laboratories, 1:2000) for 1 h at RT. After several rinsing steps, the enzymatic reaction was visualized using TMB-blotting ready-to-use substrate (Sigma-Aldrich). Prestained protein molecular weight (MW) markers were purchased from Thermo Fisher Scientific Baltics.
+ Open protocol
+ Expand
5

Quantitative Western Blot Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
SDS-PAGE was performed using standard techniques. Separated proteins were transferred to an Immobilon-P PVDF membrane (Millipore). The membrane was incubated with blocking buffer [5% skimmed milk in TBS-T (20 mM Tris, 150 mM NaCl, 0.05% Tween-20)] for 30 min. The membrane was then incubated with the primary antibodies in blocking buffer overnight at 4°C, followed by the secondary antibodies for 1 hour at 25°C. The primary antibodies were diluted as follows: mouse anti--tubulin monoclonal antibody (1:2,000) (B-5-1-2; SIGMA-Aldrich), mouse anti-acetyl--tubulin monoclonal antibody (1:500) (6-11B-1; SIGMA-Aldrich), mouse anti--actin monoclonal antibody (1:2,000), mouse anti-vinculin monoclonal antibody (1:500), mouse anti-GAPDH monoclonal antibody (1:30,000) (6C5; Millipore), rabbit anti-NMHC-IIA polyclonal antibody (1:60,000), and rabbit anti-NMHC-IIB polyclonal antibody (1:2,000). The secondary antibodies (Bio-Rad Laboratories, Hercules, CA, USA) were diluted as follows: HRP-labeled anti-mouse IgG (1:10,000) and HRP-labeled anti-rabbit IgG (1:10,000). The chemiluminescent signal was produced using the Immobilon Western Chemiluminescent HRP Substrate (Millipore) and detected using a LAS-3000 (Fujifilm, Tokyo, Japan). The percentages of cytoskeletal fractions were calculated by densitometry using ImageJ software.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!